CSBR
Champions Oncology Inc
NASDAQ: CSBR · HEALTHCARE · BIOTECHNOLOGY
$5.85
-1.01% today
Updated 2026-04-29
Market cap
$81.45M
P/E ratio
—
P/S ratio
1.41x
EPS (TTM)
$-0.18
Dividend yield
—
52W range
$6 – $10
Volume
0.0M
Champions Oncology Inc (CSBR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-4.04%
Operating margin
-1.13%
ROE
-47.60%
ROA
-4.70%
Debt/equity
1.26x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-303718.00 | — | — | — |
| 2007 | — | $-170058.00 | — | — | — |
| 2008 | $1.40M | $-411000.00 | 64.97% | -31.43% | -29.36% |
| 2009 | $3.71M | $-2.24M | 46.63% | -62.80% | -60.43% |
| 2010 | $4.89M | $-2.92M | 59.55% | -59.84% | -59.74% |
| 2011 | $6.88M | $-3.80M | 54.34% | -76.07% | -55.25% |
| 2012 | $7.15M | $-8.66M | 31.47% | -126.80% | -121.15% |
| 2013 | $8.32M | $-6.33M | 35.98% | -74.74% | -76.05% |
| 2014 | $11.55M | $-7.41M | 45.77% | -54.20% | -64.12% |
| 2015 | $8.86M | $-13.14M | 13.88% | -149.36% | -148.26% |
| 2016 | $11.18M | $-10.45M | 22.32% | -92.26% | -93.42% |
| 2017 | $15.41M | $-6.88M | 37.04% | -44.18% | -44.67% |
| 2018 | $20.24M | $-1.48M | 47.86% | -6.69% | -7.29% |
| 2019 | $27.07M | $128000.00 | 47.30% | 1.00% | 0.47% |
| 2020 | $32.12M | $-2.09M | 47.08% | -4.94% | -6.52% |
| 2021 | $41.04M | $362000.00 | 47.74% | 0.89% | 0.88% |
| 2022 | $49.11M | $548000.00 | 51.88% | 1.24% | 1.12% |
| 2023 | $53.87M | $-5.33M | 45.18% | -8.26% | -9.90% |
| 2024 | $50.16M | $-7.28M | 41.38% | -13.80% | -14.51% |
| 2025 | $56.94M | $4.70M | 47.27% | 8.51% | 8.26% |